Lab-Grown tumors used to test supercharged immune cells against breast cancer

NCT ID NCT05007379

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study collects tumor and blood samples from 100 breast cancer patients to grow mini-tumors (organoids) in the lab. Researchers will then test whether specially engineered immune cells called CAR-macrophages can destroy these mini-tumors. The goal is to see if this new cell therapy could be a future treatment for different types of breast cancer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

CAR-macrophages

What this could lead to

If the CAR-macrophages show strong activity against the organoids, this could point toward a new cell-based treatment for breast cancer.

What could go wrong

This is a very early lab study using tumor samples, not a treatment trial in patients. The approach may not work in real bodies or may have unexpected side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Oscar Lambret Center

    RECRUITING

    Lille, 59000, France

    Contact